The Cdk inhibitor p57 Kip2 controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics

Oncogene

Volumn 28, Issue 47, 2009, Pages 4175-4188

  Vlachos, P ^a   Joseph, B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Actin cytoskeleton dynamic; Cell mobility; LIMK 1; P57Kip2

Indexed keywords

ACTIN; COFILIN; CYCLIN DEPENDENT KINASE INHIBITOR 1C; FLUORESCENT DYE; LIM KINASE 1; RHO KINASE;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL DEATH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CYTOSKELETON; DYNAMICS; EMBRYO; ENZYME ACTIVITY; FEMALE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; STRESS FIBER; TURNOVER TIME;

ACTINS; ANIMALS; CELL DEATH; CELL MOVEMENT; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN-DEPENDENT KINASE INHIBITOR P57; CYTOSKELETON; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; LIM KINASES; NEOPLASM PROTEINS; NEOPLASMS;

EID: 70949083516     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.269     Document Type: Article

References (51)

1. Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard O et al. (1998). Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393: 805-809.
2. Barbe L, Lundberg E, Oksvold P, Stenius A, Lewin E, Bjornling E et al. (2008). Towards a confocal subcellular atlas of the human proteome. Mol Cell Proteomics 7: 499-508.
3. Besson A, Dowdy SF, Roberts JM. (2008). CDK inhibitors: cell cycle regulators and beyond. Dev Cell 14: 159-169.
4. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. (2004). p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 18: 862-876.
5. Blint E, Phillips AC, Kozlov S, Stewart CL, Vousden KH. (2002). Induction of p57(KIP2) expression by p73beta. Proc Natl Acad Sci USA 99: 3529-3534.
6. Bozdogan O, Atasoy P, Batislam E, Basar MM, Basar H. (2008). Significance of p57(Kip2) down-regulation in oncogenesis of bladder carcinoma: an immunohistochemical study. Tumori 94: 556-562.
7. Chim CS, Wong AS, Kwong YL. (2005). Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias. Am J Hematol 80: 282-287.
8. Chrzanowska-Wodnicka M, Burridge K. (1996). Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 133: 1403-1415.
9. Coqueret O. (2003). New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 13: 65-70.
10. Davila M, Frost AR, Grizzle WE, Chakrabarti R. (2003). LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J Biol Chem 278: 36868-36875.
11. Denicourt C, Dowdy SF. (2004). Cip/Kip proteins: more than just CDKs inhibitors. Genes Dev 18: 851-855.
12. Dyer MA, Cepko CL. (2000). p57(Kip2) regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina. Development 127: 3593-3605.
13. Fan GK, Xu F, Yang B, Fujieda S. (2006). p57(kip2) expression is related to carcinogenesis and tumor progression in laryngeal tissues. Acta Otolaryngol 126: 301-305.
14. Gonzalez S, Perez-Perez MM, Hernando E, Serrano M, Cordon-Cardo C. (2005). p73beta-mediated apoptosis requires p57kip2 induction and IEX-1 inhibition. Cancer Res 65: 2186-2192.
15. Hotulainen P, Paunola E, Vartiainen MK, Lappalainen P. (2005). Actin-depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-actin depolymerization in mammalian non-muscle cells. Mol Biol Cell 16: 649-664.
16. Itoh Y, Masuyama N, Nakayama K, Nakayama KI, Gotoh Y. (2007). The cyclin-dependent kinase inhibitors p57 and p27 regulate neuronal migration in the developing mouse neocortex. J Biol Chem 282: 390-396.
17. Jia J, Lin M, Zhang L, York JP, Zhang P. (2007). The Notch signaling pathway controls the size of the ocular lens by directly suppressing p57Kip2 expression. Mol Cell Biol 27: 7236-7247.
18. Jin RJ, Lho Y, Wang Y, Ao M, Revelo MP, Hayward SW et al. (2008). Down-regulation of p57Kip2 induces prostate cancer in the mouse. Cancer Res 68: 3601-3608.
19. Joseph B, Marchetti P, Formstecher P, Kroemer G, Lewensohn R, Zhivotovsky B. (2002). Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment. Oncogene 21: 65-77.
20. Joseph B, Wallen-Mackenzie A, Benoit G, Murata T, Joodmardi E, Okret S et al. (2003). p57(Kip2) cooperates with Nurr1 in developing dopamine cells. Proc Natl Acad Sci USA 100: 15619-15624. (Pubitemid 38021039)
21. Joseph B, Andersson ER, Vlachos P, Sodersten E, Liu L, Teixeira A et al. (2009). p57Kip2 is a repressor of Mash1 activity and neuronal differentiation in neuronal stem cells. Cell Death Differ (in press).
22. Kobatake T, Yano M, Toyooka S, Tsukuda K, Dote H, Kikuchi T et al. (2004). Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. Oncol Rep 12: 1087-1092.
23. Kobayashi M, Nishita M, Mishima T, Ohashi K, Mizuno K. (2006). MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration. EMBO J 25: 713-726.
24. Lee S, Helfman DM. (2004). Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway. J Biol Chem 279: 1885-1891.
25. Li JQ, Wu F, Usuki H, Kubo A, Masaki T, Fujita J et al. (2003). Loss of p57KIP2 is associated with colorectal carcinogenesis. Int J Oncol 23: 1537-1543.
26. Matsumoto M, Furihata M, Ohtsuki Y, Sasaguri S, Ogoshi S. (2000). Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma. Anticancer Res 20: 1947-1952.
27. McAllister SS, Becker-Hapak M, Pintucci G, Pagano M, Dowdy SF. (2003). Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol Cell Biol 23: 216-228.
28. Mizuno K, Okano I, Ohashi K, Nunoue K, Kuma K, Miyata T et al. (1994). Identification of a human cDNA encoding a novel protein kinase with two repeats of the LIM/double zinc finger motif. Oncogene 9: 1605-1612. (Pubitemid 24163386)
29. Nakai S, Masaki T, Shiratori Y, Ohgi T, Morishita A, Kurokohchi K et al. (2002). Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival. Int J Oncol 20: 769-775.
30. Nan KJ, Guo H, Ruan ZP, Jing Z, Lui SX. (2005). Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma. World J Gastroenterol 11: 1237-1240.
31. Nunoue K, Ohashi K, Okano I, Mizuno K. (1995). LIMK-1 and LIMK-2, two members of a LIM motif-containing protein kinase family. Oncogene 11: 701-710.
32. Ohashi K, Nagata K, Maekawa M, Ishizaki T, Narumiya S, Mizuno K. (2000). Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J Biol Chem 275: 3577-3582.
33. Pateras IS, Apostolopoulou K, Koutsami M, Evangelou K, Tsantoulis P, Liloglou T et al. (2006). Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer. Int J Cancer 119: 2546-2556.
34. Ridley AJ, Hall A, Chrzanowska-Wodnicka M, Burridge K. (1992). The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. Cell 70: 389-399.
35. Sakai K, Peraud A, Mainprize T, Nakayama J, Tsugu A, Hongo K et al. (2004). Inducible expression of p57KIP2 inhibits glioma cell motility and invasion. J Neurooncol 68: 217-223.
36. Samuelsson MK, Pazirandeh A, Okret S. (2002). A pro-apoptotic effect of the CDK inhibitor p57(Kip2) on staurosporine-induced apoptosis in HeLa cells. Biochem Biophys Res Commun 296: 702-709.
37. Shin JY, Kim HS, Lee KS, Kim J, Park JB, Won MH et al. (2000). Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer. Exp Mol Med 32: 79-83.
38. Sidani M, Wessels D, Mouneimne G, Ghosh M, Goswami S, Sarmiento C et al. (2007). Cofilin determines the migration behavior and turning frequency of metastatic cancer cells. J Cell Biol 179: 777-791.
39. Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tokuda M. (2002). Expression of p57kip2 and its clinical relevance in epithelial ovarian tumors. Anticancer Res 22: 3191-3196.
40. Sumi T, Hashigasako A, Matsumoto K, Nakamura T. (2006). Different activity regulation and subcellular localization of LIMK1 and LIMK2 during cell cycle transition. Exp Cell Res 312: 1021-1030.
41. Sumi T, Matsumoto K, Nakamura T. (2001). Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase. J Biol Chem 276: 670-676.
42. Suzuki A, Tsutomi Y, Yamamoto N, Shibutani T, Akahane K. (1999). Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death. Mol Cell Biol 19: 3842-3847.
43. Wang W, Mouneimne G, Sidani M, Wyckoff J, Chen X, Makris A et al. (2006). The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol 173: 395-404.
44. Watanabe H, Pan ZQ, Schreiber-Agus N, DePinho RA, Hurwitz J, Xiong Y. (1998). Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci 95: 1392-1397.
45. Vlachos P, Nyman U, Hajji N, Joseph B. (2007). The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway. Cell Death Differ 14: 1497-1507.
46. Yan Y, Frisen J, Lee MH, Massague J, Barbacid M. (1997). Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev 11: 973-983.
47. Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K et al. (1998). Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 393: 809-812.
48. Yokoo T, Toyoshima H, Miura M, Wang Y, Iida KT, Suzuki H et al. (2003). p57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus. J Biol Chem 278: 52919-52923.
49. Yoshioka K, Foletta V, Bernard O, Itoh K. (2003). A role for LIM kinase in cancer invasion. Proc Natl Acad Sci USA 100: 7247-7252.
50. Zebda N, Bernard O, Bailly M, Welti S, Lawrence DS, Condeelis JS. (2000). Phosphorylation of ADF/cofilin abolishes EGF-induced actin nucleation at the leading edge and subsequent lamellipod extension. J Cell Biol 151: 1119-1128.
51. Zhang P, Liegeois NJ, Wong C, Finegold M, Hou H, Thompson JC et al. (1997). Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387: 151-158.